DK329289D0 - Ny terapeutisk anvendelse af h2-receptorblokerende forbindelser - Google Patents

Ny terapeutisk anvendelse af h2-receptorblokerende forbindelser

Info

Publication number
DK329289D0
DK329289D0 DK329289A DK329289A DK329289D0 DK 329289 D0 DK329289 D0 DK 329289D0 DK 329289 A DK329289 A DK 329289A DK 329289 A DK329289 A DK 329289A DK 329289 D0 DK329289 D0 DK 329289D0
Authority
DK
Denmark
Prior art keywords
receptor
therapeutic use
new therapeutic
breaking compounds
breaking
Prior art date
Application number
DK329289A
Other languages
English (en)
Other versions
DK329289A (da
Inventor
Rolf Haakanson
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DK329289D0 publication Critical patent/DK329289D0/da
Publication of DK329289A publication Critical patent/DK329289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK329289A 1987-11-13 1989-07-03 Ny terapeutisk anvendelse af h2-receptorblokerende forbindelser DK329289A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8704436A SE8704436D0 (sv) 1987-11-13 1987-11-13 Anvendning av antisekretoriska substanser for nya indikationer
PCT/SE1988/000574 WO1989004178A1 (en) 1987-11-13 1988-10-27 New therapeutical use of h2-receptor-blocking compounds

Publications (2)

Publication Number Publication Date
DK329289D0 true DK329289D0 (da) 1989-07-03
DK329289A DK329289A (da) 1989-07-03

Family

ID=20370204

Family Applications (1)

Application Number Title Priority Date Filing Date
DK329289A DK329289A (da) 1987-11-13 1989-07-03 Ny terapeutisk anvendelse af h2-receptorblokerende forbindelser

Country Status (7)

Country Link
EP (1) EP0353262A1 (da)
JP (1) JPH02502188A (da)
AU (1) AU2720388A (da)
DK (1) DK329289A (da)
HU (1) HUT51894A (da)
SE (1) SE8704436D0 (da)
WO (1) WO1989004178A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
EE05603B1 (et) * 1997-07-22 2012-12-17 Merck & Co., Inc. Alendronaadi kasutamine ravimi valmistamiseks osteoporoosi raviks
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
EP3167876B1 (en) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
CN113181110A (zh) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
US4220653A (en) * 1979-01-24 1980-09-02 Vivino A Earl Administration of cimetidine to reduce appetite and facilitate weight loss in persons suffering from excessive weight
US4256743A (en) * 1979-02-22 1981-03-17 President And Fellows Of Harvard College Inhibition of bone resorption with H1 -blocking antihistamines
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine

Also Published As

Publication number Publication date
JPH02502188A (ja) 1990-07-19
SE8704436D0 (sv) 1987-11-13
AU2720388A (en) 1989-06-01
HUT51894A (en) 1990-06-28
WO1989004178A1 (en) 1989-05-18
DK329289A (da) 1989-07-03
HU886797D0 (en) 1990-05-28
EP0353262A1 (en) 1990-02-07

Similar Documents

Publication Publication Date Title
GR871212B (en) Therapeutic use of serotonin antagonist
DK208188A (da) Anvendelse af 17-ketosteroider
DK263288A (da) Farmaceutisk praeparat af cefuroxim-axetil
DK363887A (da) Anvendelse af bromcruptin
DK399088A (da) Anvendelse af olefine forbindelser
DK329289D0 (da) Ny terapeutisk anvendelse af h2-receptorblokerende forbindelser
IT8722783A0 (it) Procedimento di sintesi dell'amikacina
DK185988A (da) Anvendelse af antigen
DK365588D0 (da) Indretning tl fastgoerelse af forankringselementer
DK537687A (da) Fremgangsmaade til fremstilling af n-substituerede piperazinoner
DK293086A (da) Anvendelse af substituerede azabicycloforbindelser
DK87888D0 (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
DK316589D0 (da) Substituerede azacyclohexylderivater af rifamyciner
IT1158450B (it) Procedimento per la preparazione dell'eritro-alfa-2-piperidil-2,8-bis-(trifluorometil)-4-chinolinmetanolo
DK415087D0 (da) Terapeutiske midler indeholdende benzhydrylthiomethanderivater
DK245388A (da) Brug af dopaminreceptoragonister
DK175587A (da) Fremstilling af substituerede (dichlormethyl)-pyridiner
DK471287A (da) Fremstilling af substitueret amid
DK115088A (da) Indretning til sammensoemning af konstruktionsdele
ZA893146B (en) Therapeutic use of serotonin antagonists
KR870011914U (ko) 착탈식 화운데이숀의 착설구조
ZA903015B (en) Therapeutic use of 5-ht3 receptor antagonists
IT8748006A0 (it) Dispositivo-copri auricolare per la salvaguardia igienica dell'utenza telefonica
ES292771Y (es) Anillo terapeutico
IT8821146A0 (it) Dispositivo perfezionato per la potabilizzazione dell'acqua.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment